An inducible long noncoding RNA amplifies DNA damage signaling - PubMed (original) (raw)
. 2016 Nov;48(11):1370-1376.
doi: 10.1038/ng.3673. Epub 2016 Sep 26.
Julia T Garcia 1, Tiffany Hung 1, Ryan A Flynn 1, Ying Shen 1, Kun Qu 1, Alexander Y Payumo 3 4, Ashwin Peres-da-Silva 1, Daniela Kenzelmann Broz 5, Rachel Baum 6, Shuling Guo 7, James K Chen 3 4, Laura D Attardi 2 5, Howard Y Chang 1
Affiliations
- PMID: 27668660
- PMCID: PMC5083181
- DOI: 10.1038/ng.3673
An inducible long noncoding RNA amplifies DNA damage signaling
Adam M Schmitt et al. Nat Genet. 2016 Nov.
Abstract
Long noncoding RNAs (lncRNAs) are prevalent genes with frequently precise regulation but mostly unknown functions. Here we demonstrate that lncRNAs guide the organismal DNA damage response. DNA damage activated transcription of the DINO (Damage Induced Noncoding) lncRNA via p53. DINO was required for p53-dependent gene expression, cell cycle arrest and apoptosis in response to DNA damage, and DINO expression was sufficient to activate damage signaling and cell cycle arrest in the absence of DNA damage. DINO bound to p53 protein and promoted its stabilization, mediating a p53 auto-amplification loop. Dino knockout or promoter inactivation in mice dampened p53 signaling and ameliorated acute radiation syndrome in vivo. Thus, inducible lncRNA can create a feedback loop with its cognate transcription factor to amplify cellular signaling networks.
Conflict of interest statement
S.G. is an employee of Ionis Pharmaceuticals. The other authors declare no competing financial interests.
Figures
Figure 1. DINO encodes a p53-dependent DNA damage-induced transcript
(a) Upper Panel: Transcription across the CDKN1A locus in human fibroblasts before or after 24 hours of doxorubicin (Dox) treatment, (Hung et al., 2011). Lower Panel: p53 ChIP-seq in untreated or doxorubicin treated U2OS cells. (b) Time course of DINO and CDKN1A expression in human fibroblasts after DNA damage. Below: p53 and histone H3 immunoblot (WB). Mean +/− s.d are shown, n = 3. (c) DINO expression and p53 immunoblot in fibroblasts treated with siCDKN1A or siTP53 24 hours prior to dox treatment. Mean +/− s.d. are shown, n = 3. (d) DINO expression and p53 immunoblot in p53+/+ wildtype (WT) or p53−/− HCT116 cells +/− Dox (16hr). Mean +/− s.d are shown, n = 3. See also Supplementary Figs. 1–2.
Figure 2. Loss of DINO abrogates DNA damage-induced gene regulation and cell cycle arrest
(a) DINO and CDKN1A expression in fibroblasts treated with the indicated siRNAs in the presence or absence of doxorubicin (24hr), as measured by qRT-PCR. Mean +/− s.d. are shown; *, P < 0.05 compared to siCTRL (students T-test), n = 3. (b) Columns 1 and 2: heatmap of genes > 2 fold changed in fibroblasts upon DNA damage with doxorubicin (26hr) by microarray analysis. Same genes were represented as DINO knockdown + Dox relative to control + Dox in columns 3–5. (c) Genome-wide chromatin accessibility at p53 binding elements in fibroblasts treated with doxorubicin and DINO knockdown as indicated (24hr), as measured by ATAC-seq. Mean +/− s.e.m are shown. * P = 1.2 × 10−4, Control ASO (n = 4), Control ASO + Dox (n = 4), DINO ASO (n = 6), DINO ASO + Dox (n = 7). (d) p53 ChIP-qPCR at indicated promoters in control or DINO knockdown fibroblasts treated with doxorubicin (24hr). Mean +/− s.d are shown, n = 3. (e) Cell cycle arrest following 26 hours of doxorubicin treatment in shControl and shDINO U2OS cells. See also Supplementary Fig. 3 and Supplementary Tables 1–2.
Figure 3. p53 is a DINO-binding protein
(a) Left: Summary of RNA chromatography with DINO retrieval of proteins from whole cell lysate of doxorubicin (24hr) treated fibroblasts. Right: RNA chromatography using 6 pmol RNA and 1 ug of each recombinant protein as indicated. (b) RNA IP of p53 in human fibroblasts followed by qRT-PCR of DINO, GAPDH and U6 snRNA. *, P < 0.05 compared to IgG control (students T-test). Mean +/− s.d. are shown, n = 3. (c) UV crosslinking and immunoprecipitation (CLIP) of p53-bound DINO RNA in doxorubicin (24hr) treated human fibroblasts. qRT-PCR identifies the DINO region bound by p53 in vivo. Location of primer pairs along the DINO transcript indicated in the diagram above. Bottom: Immunoblot of p53 retrieved by CLIP. Mean +/− s.d. are shown, n = 3. (d) p53 RIP of DINO with the indicated p53 constructs in p53−/− H1299 cells. Mean +/− s.d. are shown, n = 3. See also Supplementary Fig. 4.
Figure 4. DINO stabilizes p53 and enhances regulation of its target genes
(a) Immunoblot of p53, p53 phospho-S9, and p21 in shControl (shSCR) and shDINO U2OS cells. Doxorubicin (12hr) was used at the following concentrations: 0, 0.05, 0.1, 0.2 ug/ml. (b) Human or mouse DINO expression stabilizes p53 in fibroblasts, as indicated by cycloheximide (CHX) chase analysis. p53 and p21 levels at indicated hours post cycloheximide addition. p53 densitometry values are indicated below. (c) p53 target gene expression in 293 cells with empty vector, DINO overexpression, doxorubicin treatment (16hr), or DINO + doxorubicin. Left: nCounter quantification. Right: confirmation using qRT-PCR. Mean +/− s.d. are shown; *, P < 0.05 (students T-test), n = 3. (d) Cell cycle analysis of BrdU/PI labeled 293 cells transfected with DINO. (e) p53 retrieval of wildtype DINO or a DINO mutant lacking the putative p53 binding site, measured by p53 CLIP-qRT-PCR. Mean +/− s.d. are shown, n = 3. (f) qRT-PCR for p53 target genes in 293 cells transfected with vector, full length DINO, or DINO deletion mutants DINOΔ323–405 or DINOΔ320–450 that lack the CLIP RNA fragment. Blue box indicates the primary p53 binding site identified by UV-CLIP-qPCR. Mean +/− s.d. are shown, n = 3. See also Supplementary Fig. 5.
Figure 5. Germline disruption of mouse Dino impairs the p53-dependent, DNA damage-induced apoptosis
(a) Design of the Dinogfp allele. (b) DNA damage induces Dino and Cdkn1a expression in MEFs of indicated genotype 16 hours after 0.2 ug/mL doxorubicin, measure by qRT-PCR. Mean +/− s.d. are shown, n = 3. (c) qRT-PCR of DNA damage inducible, p53 responsive genes in MEFs of indicated genotype under conditions of physiologic oxygen (2%). Mean +/− s.d. are shown, n = 3. (d) Relative apoptotic and viable fractions of thymocytes of indicated genotypes 6 hours after 1 Gy irradiation. Mean +/− s.d. are shown, ** P < 0.01 (students T-test), n = 3. (e) Kaplan Meier survival curve of mice treated with a single fraction of lethal total body irradiation of 12 Gy. P < 0.01 (log-rank test for trend). See also Supplementary Fig. 6.
Figure 6. Dino regulates the DNA damage response in both a p21-dependent and p21-independent manner
(a) Design of Dinolox allele. (b) Dinolox/lox inactivates basal and DNA-damage inducible expression of Dino lncRNA. Dino expression in MEFs with indicated genotypes +/− 0.2ug/mL dox for 8 hours is measured by qRT-PCR. p53−/− MEFs is shown for comparison. Mean +/− s.d. are shown, n = 3. (c) qRT-PCR of p53-dependent transcripts in MEFs of indicated genotype 8 hours after treatment with the indicated doses of doxorubicin. Mean +/− s.d. are shown, n = 3. (d) p53 protein abundance following DNA damage with dox. Top: Immunoblot. Bottom: Quantification of p53 and p21 protein abundance normalized to beta-tubulin. Summed area under the curve [AUC] shows 40% reduction of p53 protein accumulation in Dinolox/lox cells. (e) Cell cycle analysis of doxorubicin-treated Dino+/+ and Dinolox/lox MEFs. Mean +/− s.d. are shown, n = 3. (f) Population doublings of serially passaged primary Dino+/+ and Dinolox/lox MEFs. See also Supplementary Fig. 7.
Figure 7
Model of DINO function in p53 signaling.
Similar articles
- KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
Sharma S, Munger K. Sharma S, et al. J Virol. 2020 Jun 1;94(12):e02178-19. doi: 10.1128/JVI.02178-19. Print 2020 Jun 1. J Virol. 2020. PMID: 32269126 Free PMC article. - NR2E3 is a key component in p53 activation by regulating a long noncoding RNA DINO in acute liver injuries.
Khanal T, Leung YK, Jiang W, Timchenko N, Ho SM, Kim K. Khanal T, et al. FASEB J. 2019 Jul;33(7):8335-8348. doi: 10.1096/fj.201801881RR. Epub 2019 Apr 16. FASEB J. 2019. PMID: 30991008 Free PMC article. - P53 long noncoding RNA regulatory network in cancer development.
Aravindhan S, Younus LA, Hadi Lafta M, Markov A, Ivanovna Enina Y, Yushchenkо NA, Thangavelu L, Mostafavi SM, Pokrovskii MV, Ahmadi M. Aravindhan S, et al. Cell Biol Int. 2021 Aug;45(8):1583-1598. doi: 10.1002/cbin.11600. Epub 2021 Apr 8. Cell Biol Int. 2021. PMID: 33760334 Review. - Long noncoding RNAs in the regulation of p53-mediated apoptosis in human cancers.
Chatterjee M, Viswanathan P. Chatterjee M, et al. Cell Biol Int. 2021 Jul;45(7):1364-1382. doi: 10.1002/cbin.11597. Epub 2021 Apr 12. Cell Biol Int. 2021. PMID: 33760332 Review.
Cited by
- Cellular and epigenetic perspective of protein stability and its implications in the biological system.
Manav N, Jit BP, Kataria B, Sharma A. Manav N, et al. Epigenomics. 2024;16(11-12):879-900. doi: 10.1080/17501911.2024.2351788. Epub 2024 Jun 17. Epigenomics. 2024. PMID: 38884355 Review. - The Loss of an Orphan Nuclear Receptor NR2E3 Augments Wnt/β-catenin Signaling via Epigenetic Dysregulation that Enhances Sp1-β catenin-p300 Interactions in Hepatocellular Carcinoma.
Leung YK, Lee SG, Wang J, Guruvaiah P, Rusch NJ, Ho SM, Park C, Kim K. Leung YK, et al. Adv Sci (Weinh). 2024 Aug;11(29):e2308539. doi: 10.1002/advs.202308539. Epub 2024 May 24. Adv Sci (Weinh). 2024. PMID: 38790135 Free PMC article. - miRNAs as Interconnectors between Obesity and Cancer.
González-Sánchez GD, Granados-López AJ, López-Hernández Y, Robles MJG, López JA. González-Sánchez GD, et al. Noncoding RNA. 2024 Apr 15;10(2):24. doi: 10.3390/ncrna10020024. Noncoding RNA. 2024. PMID: 38668382 Free PMC article. Review. - Long non-coding RNA generated from CDKN1A gene by alternative polyadenylation regulates p21 expression during DNA damage response.
Murphy MR, Ramadei A, Doymaz A, Varriano S, Natelson DM, Yu A, Aktas S, Mazzeo M, Mazzeo M, Zakusilo G, Kleiman FE. Murphy MR, et al. Nucleic Acids Res. 2023 Nov 27;51(21):11911-11926. doi: 10.1093/nar/gkad899. Nucleic Acids Res. 2023. PMID: 37870464 Free PMC article. - Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis.
Scholda J, Nguyen TTA, Kopp F. Scholda J, et al. Hum Genet. 2024 Jul;143(7):813-829. doi: 10.1007/s00439-023-02604-7. Epub 2023 Oct 2. Hum Genet. 2024. PMID: 37782337 Free PMC article. Review.
References
- Komarova EA, et al. Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene. 2004;23:3265–71. - PubMed
- Westphal CH, et al. Loss of atm radiosensitizes multiple p53 null tissues. Cancer Res. 1998;58:5637–9. - PubMed
MeSH terms
Substances
Grants and funding
- T32 CA009302/CA/NCI NIH HHS/United States
- R01 HG004361/HG/NHGRI NIH HHS/United States
- DP1 HD075622/HD/NICHD NIH HHS/United States
- K12 GM081266/GM/NIGMS NIH HHS/United States
- P50 GM107615/GM/NIGMS NIH HHS/United States
- T32 HG000044/HG/NHGRI NIH HHS/United States
- R01 ES023168/ES/NIEHS NIH HHS/United States
- R01 CA118750/CA/NCI NIH HHS/United States
- P30 CA124435/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous